Other grades of this product :
| Ixazomib citrate (USAN) Basic information |
| Product Name: | Ixazomib citrate (USAN) | | Synonyms: | Ixazomib citrate (USAN);2-[(1R)-1-[[2-[(2,5-Dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diacetic acid;2,2'-(2-(1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-5-oxo-1,3,2-dioxaborolane-4,4-diyl)diacetic acid;IXAZOMIB CITRATE;MLN 9708;MLN-9708;(R)-2,2'-(2-(1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-5-oxo-1,3,2-dioxaborolane-4,4-diyl)diacetic acid;Ixazomib citrate(MLN9708);IXAZOMIB; MLN-9708;MLN9708;MLN 9708;2-[4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolan-4-yl]acetic acid | | CAS: | 1239908-20-3 | | MF: | C20H23BCl2N2O9 | | MW: | 517.12 | | EINECS: | | Product Categories: | API | | Mol File: | 1239908-20-3.mol |
| Ixazomib citrate (USAN) Chemical Properties |
| density | 1.47±0.1 g/cm3(Predicted) | | pka | 3.59±0.10(Predicted) |
| Ixazomib citrate (USAN) Usage And Synthesis |
| Definition | ChEBI: A glycine derivative that is the amide obtained by formal condensation of the carboxy group of N-(2,5-dichlorobenzoyl)glycine with the amino group of 2,2'-{2-[(1R)-1-amino-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diy
}diacetic acid. A prodrug for ixazomib that is used in combination therapy for treatment of multiple myeloma. |
| Ixazomib citrate (USAN) Preparation Products And Raw materials |
|
日本语
한국어
Français
Deutsch
España
Türkiye